Linnaeus Therapeutics closed a $4.48 million equity round and won up to $22 million from a federal health agency. The company is studying pathways that may influence aging and disease.
This new framework is designed to provide brands with a 'brand-friendly' anchor in an ecosystem increasingly dominated by autonomous shoppers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results